50 research outputs found

    Two Welsh surveys of blood lead and blood pressure.

    Get PDF
    The relationship between blood pressure and blood lead was examined in two population samples. One of these consisted of 1137 men aged 49 to 65 years, the other of 865 men and 856 women aged 18 to 64 years. Neither population had any known important exposure to lead, and the 95% ranges of blood lead levels were 6 to 26 micrograms/100 mL and 6 to 23 micrograms/mL in the men and 5 to 18 micrograms/100 mL in the women. No significant relationship between blood pressure and blood lead was detected in either of the population samples, and the regression coefficients suggest that if there were a real effect, then the mean difference in blood pressure per 10 micrograms difference in blood lead is likely to be 0.7 mm Hg in both systolic and diastolic pressures. In the survey of 1137 men, the rise in blood pressure was measured during the cold pressor test. This test is likely to be affected if lead were to affect neurogenic mediators of blood pressure. The mean change in systolic pressure was 24 mm Hg and the 95% range was -6 to 60 mm Hg, but there was no evidence of any association with blood lead level

    The labels and models used to describe problematic substance use impact discrete elements of stigma: A registered report.

    Get PDF
    Objectives: Problematic substance use is one of the most stigmatized health conditions leading research to examine how the labels and models used to describe it influence public stigma. Two recent studies examine whether beliefs in a disease model of addiction influence public stigma but result in equivocal findings—in line with the mixed-blessings model, Kelly et al. (2021) found that while the label “chronically relapsing brain disease” reduced blame attribution, it decreased prognostic optimism and increased perceived danger and need for continued care; however, Rundle et al. (2021) conclude absence of evidence. This study isolates the different factors used in these two studies to assess whether health condition (drug use vs. health concern), etiological label (brain disease vs. problem), and attributional judgment (low vs. high treatment stability) influence public stigma toward problematic substance use. Method: Overall, 1,613 participants were assigned randomly to one of the eight vignette conditions that manipulated these factors. They completed self-report measures of discrete and general public stigma and an indirect measure of discrimination. Results: Greater social distance, danger, and public stigma but lower blame were ascribed to drug use relative to a health concern. Greater (genetic) blame was reported when drug use was labelled as a “chronically relapsing brain disease” relative to a “problem.” Findings for attributional judgment were either inconclusive or statistically equivalent. Discussion: The labels used to describe problematic substance use appear to impact discrete elements of stigma. We suggest that addiction is a functional attribution, which may explain the mixed literature on the impact of etiological labels on stigma to date

    Introduction to Physiological and Pathological Chemistry (9th Edition)

    No full text

    Further evidence of a fall in blood lead levels in Wales.

    No full text
    Random samples of residents in North Wales, some of whom had been seen in 1976 and others in 1981, were seen again in 1984. Blood lead estimations indicated that there had been a fall of about 5% per year. This is similar to the fall we estimated from two previous studies in Wales and is comparable to changes described in the USA and New Zealand

    Air lead, blood lead and travel by car

    No full text
    Evidence on the relevance of lead in petrol to lead in blood has come from two main sources. Cross sectional studies of blood lead levels in population samples and in the air to which they are exposed suggest that petrol makes only a very small contribution. However longitudinal studies in the USA in which changes in lead levels in petrol and changes in blood lead have been studied suggest that petrol makes a substantial contribution to blood lead. The possibility that this discrepancy might be explained by the exposure of subjects to very high levels of lead when travelling in motor vehicles is examined, and rejected
    corecore